Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake

被引:33
作者
Ji Chen
Russell D. Folks
Liudmila Verdes
Daya N. Manatunga
Arnold F. Jacobson
Ernest V. Garcia
机构
[1] Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322
[2] GE Healthcare, Princeton, NJ
关键词
Heart failure; I-123; mIBG; SPECT; Sympathetic nervous system;
D O I
10.1007/s12350-011-9438-0
中图分类号
学科分类号
摘要
Background. The purpose of this study was to evaluate global quantitation of cardiac uptake on I-123 mIBG SPECT. Methods. The study included a pilot group of 67 subjects and a validation group of 1,051 subjects. SPECT images were reconstructed by filtered backprojection, ordered subsets expectation maximization, and deconvolution of septal penetration, respectively. SPECT heartto- mediastinum ratio (H/M) was calculated by comparing the mean counts between heart and mediastinum volumes of interest drawn on transaxial images. Receiver operating characteristic (ROC) analysis was used to assess the capability of each SPECT method to differentiate the heart disease subjects from controls in comparison with that of the planar H/M. Results. In the validation group, the areas under the ROC curves were not significantly different between the SPECT and planar H/M. Order subsets expectation maximization had significantly larger area under the ROC curve than the other two SPECT methods. Conclusion. H/M obtained from I-123 mIBG SPECT was equivalent to the planar H/M for differentiating between subjects with normal and abnormal mIBG uptake. Global quantification of cardiac I-123 mIBG SPECT may represent a viable alternative to the planar H/M. Copyright © 2011 American Society of Nuclear Cardiology.
引用
收藏
页码:92 / 99
页数:7
相关论文
共 23 条
[1]  
Henneman M.M., Bengel F.M., Van Der Wall E.E., Knuuti J., Bax J.J., Cardiac neuronal imaging: Application in the evaluation of cardiac disease, J Nucl Cardiol, 15, pp. 442-455, (2008)
[2]  
Merlet P., Benvenuti C., Moyse D., Pouillart F., Dubois-Rande J.-L., Duval A.-M., Loisance D., Castaigne A., Syrota A., Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy, Journal of Nuclear Medicine, 40, 6, pp. 917-923, (1999)
[3]  
Fujimoto S., Inoue A., Hisatake S., Yamashina S., Yamashina H., Nakano H., Yamazaki J., Usefulness of <sup>123</sup>I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of β-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis, European Journal of Nuclear Medicine and Molecular Imaging, 31, 10, pp. 1356-1361, (2004)
[4]  
Nakata T., Wakabayashi T., Kyuma M., Takahashi T., Tsuchihashi K., Shimamoto K., Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure, European Journal of Nuclear Medicine and Molecular Imaging, 32, 2, pp. 186-194, (2005)
[5]  
Anastasiou-Nana M.I., Terrovitis J.V., Athanasoulis T., Karaloizos L., Geramoutsos A., Pappa L., Tsagalou E.P., Efentakis S., Nanas J.N., Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, American Journal of Cardiology, 96, 3, pp. 427-431, (2005)
[6]  
Arimoto T., Takeishi Y., Niizeki T., Nozaki N., Hirono O., Watanabe T., Nitobe J., Tsunoda Y., Suzuki S., Koyama Y., Kitahara T., Okada A., Takahashi K., Kubota I., Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure, Journal of Cardiac Failure, 13, 1, pp. 34-41, (2007)
[7]  
Kioka H., Yamada T., Mine T., Morita T., Tsukamoto Y., Tamaki S., Masuda M., Okuda K., Hori M., Fukunami M., Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging, Heart, 93, 10, pp. 1213-1218, (2007)
[8]  
Kasama S., Toyama T., Kumakura H., Takayama Y., Ichikawa S., Suzuki T., Kurabayashi M., Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy, Journal of the American College of Cardiology, 41, 4, pp. 574-581, (2003)
[9]  
Kasama S., Toyama T., Hatori T., Sumino H., Kumakura H., Takayama Y., Ichikawa S., Suzuki T., Kurabayashi M., Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol, European Heart Journal, 28, 8, pp. 989-995, (2007)
[10]  
Kakuchi H., Sasaki T., Ishida Y., Komamura K., Miyatake K., Clinical usefulness of <sup>123</sup>I meta-iodobenzylguanidine imaging in predicting the effectiveness of β blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment, Heart, 81, 2, pp. 148-152, (1999)